Related references
Note: Only part of the references are listed.Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Pablo Angulo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Exploring targeted therapy of osteosarcoma using proteomics data
Parunya Chaiyawat et al.
ONCOTARGETS AND THERAPY (2017)
Molecular genetics of osteosarcoma
Kirby Rickel et al.
BONE (2017)
A novel co-culture model of murine K12 osteosarcoma cells and S-aureus on common orthopedic implant materials: 'the race to the surface' studied in vitro
David B. McConda et al.
BIOFOULING (2016)
The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection
J. P. Pei et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment
Jing Li et al.
ONCOTARGET (2016)
MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection
Yong Q. Cheng et al.
IMMUNOLOGY (2015)
Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation
Binh L. Phong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Systematic review and meta-analysis of objective and subjective quality of life among pediatric, adolescent, and young adult bone tumor survivors
Jamie Stokke et al.
PEDIATRIC BLOOD & CANCER (2015)
Tim-3 and Tim-4 as the potential targets for antitumor therapy
Lin Cheng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
Yu-Hwa Huang et al.
NATURE (2015)
Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Patients With Osteosarcoma
Michael Roth et al.
CANCER (2014)
PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
Julien Fourcade et al.
CANCER RESEARCH (2014)
Regulation of T cell responses by the receptor molecule Tim-3
Jacob V. Gorman et al.
IMMUNOLOGIC RESEARCH (2014)
Comment on Tim-3 Directly Enhances CD8 T Cell Responses to Acute Listeria monocytogenes Infection
Vijay K. Kuchroo et al.
JOURNAL OF IMMUNOLOGY (2014)
Tim-3 Directly Enhances CD8 T Cell Responses to Acute Listeria monocytogenes Infection
Jacob V. Gorman et al.
JOURNAL OF IMMUNOLOGY (2014)
Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
Ana C. Anderson
CANCER IMMUNOLOGY RESEARCH (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma
Maya Kansara et al.
ONCOIMMUNOLOGY (2014)
Translational biology of osteosarcoma
Maya Kansara et al.
NATURE REVIEWS CANCER (2014)
New molecular insights into osteosarcoma targeted therapy
Jilong Yang et al.
CURRENT OPINION IN ONCOLOGY (2013)
Diffusion MRI and Novel Texture Analysis in Osteosarcoma Xenotransplants Predicts Response to Anti-Checkpoint Therapy
Parastou Foroutan et al.
PLOS ONE (2013)
New targets and approaches in osteosarcoma
Jonathan Gill et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis
Atta Goudarzi et al.
Cancers (2013)
Share Paper
